MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Fluticasone furoate

CAS No. : 397864-44-7

MCE 国际站：Fluticasone furoate

产品活性：Fluticasone furoate 是一种局部，鼻内，增强亲和力的合成的三氟皮质类固醇，K_d 为 0.3 nM。Fluticasone furoate 具有有效的抗炎和抗哮喘活性，并且全身暴露率低。Fluticasone furoate 可用于过敏性鼻炎的研究。

研究领域：Immunology/Inflammation  |  Vitamin D Related/Nuclear Receptor

作用靶点：Glucocorticoid Receptor

In Vitro: Fluticasone furoate comes in a nasal spray, as an aqueous suspension of micronized fluticasone furoate for topical administration to the nasal mucosa by means of a metering, atomizing spray pump.
Fluticasone furonate displays great potency in inhibiting tumor necrosis factor synthesis and action. Fluticasone furonate is also potent in preventing damage to cultured human lung epithelial cells by different stimulus.

In Vivo: Fluticasone furonate is 99.4% bound to plasma protein in vitro and other research indicated extensive first-pass metabolism of the absorbed drug. Protein binding is highly relevant because only the unbound free drug can exert an effect at the receptor site. Clearance of Fluticasone furonate is primarily by hydrolysis in the liver by the cytochrome P450 isozyme (CYP) 3A4 that converts the drug to the 17β-carboxylic acid metabolite (M10), which displays low glucocorticoid receptor agonist potency. Fluticasone furonate is excreted mainly in the feces, with only minor amounts in the urine.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  FDA-Approved Drug Library  |  Drug Repurposing Compound Library  |  Lipid Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  EMA-Approved Drug Library  |  Nuclear Receptor Compound Library  |  Heterocyclic Compound Library  |  Pain-Related Compound Library  |  Off-patent Drug Library  |  Medroxyprogesterone acetate-d₃  |  Prednisolone acetate  |  Clobetasone butyrate  |  Mifepristone-¹³C,d₃  |  Deflazacort  |  C108297  |  Nenocorilant  |  Methylprednisolone succinate  |  Medroxyprogesterone acetate  |  Betamethasone 21-phosphate-d₅  |  Betamethasone dipropionate-d₁₀  |  Fluticasone propionate-d₅  |  Methylprednisolone-d₅  |  Fluticasone furoate-d₃  |  Dexamethasone-d₄  |  Mizacorat  |  Beclometasone dipropionate  |  Mifepristone-d₃  |  Methylprednisolone-d₂  |  Beclometasone dipropionate-d₁₀  |  Prednisone-d₈  |  Prednisolone Tebutate  |  Hydrocortisone hemisuccinate  |  Betamethasone-d₅-1  |  OP-3633  |  Glucocorticoid receptor agonist-1  |  Triamcinolone Benetonide

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。